Horizon Therapeutics Public (NASDAQ:HZNP) Earnings Information
Horizon Therapeutics Public last posted its earnings results on February 23rd, 2021. The biopharmaceutical company reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.22. Horizon Therapeutics Public has generated $1.94 earnings per share over the last year and currently has a price-to-earnings ratio of 24.2. Horizon Therapeutics Public has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.
Horizon Therapeutics Public Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Horizon Therapeutics Public (NASDAQ:HZNP) Earnings Estimates
2021 EPS Consensus Estimate: $3.44
2022 EPS Consensus Estimate: $5.46
Horizon Therapeutics Public (NASDAQ HZNP) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)